i
Hepatitis C Continuum of Care and Utilization of Healthcare and Harm Reduction Services among Persons who Inject Drugs in Seattle
-
December 26 2018
-
-
Source: Drug Alcohol Depend. 195:114-120
[PDF-472.92 KB]
Details:
-
Alternative Title:Drug Alcohol Depend
-
Personal Author:
-
Description:Background:
To describe the “continuum of care” for hepatitis C virus (HCV) and related health service utilization among persons who inject drugs (PWID) in the Seattle metropolitan area.
Methods:
The study analyzed data from the 2015 National HIV Behavioral Surveillance system focused on PWID, which included local questions on HCV treatment and testing. We calculated respondent driven sampling (RDS)-adjusted percentages of participants who had completed each step of the care continuum and compared healthcare harm reduction services among participants who were HCV+ vs. HCV- using bivariate analyses.
Results:
513 PWID were screened for HCV antibodies (Ab). Of those, 59.7% were HCV Ab+. Among those HCV Ab+, 86.4% had been tested for HCV at least once; 69.9% reported a previous diagnosis. Of those diagnosed, 55.9% had received a confirmatory test, 17.2% had ever received any medications for HCV, and 7.2% had completed treatment. The majority of HCV Ab+ participants had seen a health care provider in the past 12 months (85.6%).
Conclusions:
There is a large gap between HCV screening and treatment among Seattle area PWID.
-
Subjects:
-
Source:
-
Pubmed ID:30611979
-
Pubmed Central ID:PMC6440747
-
Document Type:
-
Funding:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
